These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 25051937)
61. Rationale and design of the PeriOperative ISchemic Evaluation-2 (POISE-2) trial: an international 2 × 2 factorial randomized controlled trial of acetyl-salicylic acid vs. placebo and clonidine vs. placebo in patients undergoing noncardiac surgery. Devereaux PJ; Am Heart J; 2014 Jun; 167(6):804-9.e4. PubMed ID: 24890528 [TBL] [Abstract][Full Text] [Related]
62. Aspirin for the prevention of cardiovascular disease: recommendation statement. Am Fam Physician; 2011 Jun; 83(12):1464-8. PubMed ID: 21671547 [No Abstract] [Full Text] [Related]
63. I Do Not Have Heart Disease-Should I Be Taking Aspirin? Karmali KN; Huffman MD JAMA Cardiol; 2017 Jul; 2(7):824. PubMed ID: 28724135 [No Abstract] [Full Text] [Related]
64. Patterns of aspirin use before hospitalization for acute myocardial infarction. Lorenz DP; Lee DP; Alderman E Am J Cardiol; 2000 Jul; 86(2):214-6. PubMed ID: 10913485 [No Abstract] [Full Text] [Related]
65. Estimating the prevalence of aspirin use in the prevention of myocardial infarction. Mittleman MA Am J Cardiol; 2000 Dec; 86(12):1402. PubMed ID: 11192746 [No Abstract] [Full Text] [Related]
66. An aspirin a day: advice that makes sense. Jacobi J Am J Health Syst Pharm; 1997 Sep; 54(17):1949. PubMed ID: 9290891 [No Abstract] [Full Text] [Related]
70. Aspirin and myocardial infarction: is one positive study enough? Verheugt FW Eur Heart J; 1995 Jul; 16 Suppl E():13-5. PubMed ID: 8542872 [No Abstract] [Full Text] [Related]
71. Antiplatelet agents prevent cardiac events in patients with coronary artery disease. Ishikawa K Intern Med; 1998 Feb; 37(2):199-202. PubMed ID: 9550609 [No Abstract] [Full Text] [Related]
72. Aspirin therapy. Carlson JE J Am Geriatr Soc; 1999 Jan; 47(1):120-1. PubMed ID: 9920243 [No Abstract] [Full Text] [Related]
73. The first randomized trial of aspirin for heart attack and the advent of systematic overviews of trials. Elwood P J R Soc Med; 2006 Nov; 99(11):586-8. PubMed ID: 17082305 [No Abstract] [Full Text] [Related]
74. Improving aspirin prophylaxis after myocardial infarction in primary care: collaboration in multipractice audit between primary care audit group and health authority. Khunti K; Sorrie R; Jennings S; Farooqi A BMJ; 1999 Jul; 319(7205):297. PubMed ID: 10426745 [No Abstract] [Full Text] [Related]
75. Aspirin - have we had the answer all along? Haddad FS Bone Joint J; 2016 May; 98-B(5):577-8. PubMed ID: 27143724 [No Abstract] [Full Text] [Related]
77. [Acetylsalicylic acid-renaissance with venous thrombosis? ]. Verspohl EJ Med Monatsschr Pharm; 2016 Jan; 39(1):37-9. PubMed ID: 26975177 [No Abstract] [Full Text] [Related]
78. Intensive blood pressure lowering warranted. Results of the HOT study: an epitaph for the J-curve concept in hypertension. Ibsen H J Hum Hypertens; 1998 Nov; 12(11):731-2. PubMed ID: 9844941 [No Abstract] [Full Text] [Related]
79. [Antiplatelet therapy and dermatological surgery]. Sei JF Ann Dermatol Venereol; 2007 Oct; 134(10 Pt 1):729-30. PubMed ID: 17978708 [No Abstract] [Full Text] [Related]
80. An international perspective on low-dose aspirin for the primary prevention of myocardial infarction. Dasa O; Pepine CJ; Pearson TA Int J Cardiol; 2023 Feb; 373():17-22. PubMed ID: 36442672 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]